Detalhe da pesquisa
1.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
2.
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Nat Commun
; 14(1): 1285, 2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36890137
3.
MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
Front Oncol
; 12: 890871, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35924144
4.
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse.
Cancer Discov
; 12(6): 1449-1461, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35255120
5.
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors.
Ther Adv Hematol
; 13: 20406207221090882, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747461
6.
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia.
Front Oncol
; 12: 1100105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733349
7.
Nanosphere's Verigene® Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance.
Clin Hematol Int
; 1(2): 120-123, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595420
8.
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience.
Bone Marrow Transplant
; 57(4): 678-680, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124695